Cherng Huei Kong1,2, Glenn D Guest1,3, Douglas A Stupart1,3, Ian G Faragher2,4, Steven T F Chan2,5, David A Watters1,3. 1. Department of Surgery, Barwon Health, Geelong, Victoria, Australia. 2. North West Academic Centre, The University of Melbourne, Melbourne, Victoria, Australia. 3. School of Medicine, Deakin University, Geelong, Victoria, Australia. 4. Division of Surgery, Western Hospital, Melbourne, Victoria, Australia. 5. Department of Surgery, Sunshine Hospital, Melbourne, Victoria, Australia.
Abstract
BACKGROUND: Colorectal surgery carries a significant mortality risk, with reported rates of 1-6% for elective surgery and up to 22% in the emergency setting. Both clinicians and patients will benefit from being able to predict the likelihood of death before surgery. Recently, we have described and validated two risk stratification models for colorectal surgery, the Barwon Health 2012 and Association Française de Chirurgie models. However, these models are not suitable for assessment at patient's bedside. The purpose of this study is to develop a simplified preoperative model capable of predicting mortality following colorectal surgery. METHODS: The new model is termed Colorectal preOperative Surgical Score (CrOSS). The development and internal validation of CrOSS was performed using a prospectively maintained colorectal database. External validation was performed using retrospective data. Univariate and multivariate analyses were performed in model development. Calibration and discrimination were used for model validation. RESULTS: There were 474 and 389 consecutive colorectal surgeries at Geelong Hospital and Western Hospital. Overall mortality rates were 5.16% and 1.03%, respectively. Significant predictors for mortality were as follows: age ≥70, urgent operation, albumin ≤30 g/L and congestive heart failure (receiver operating characteristic (ROC) = 0.870, calibration P-value = 0.937). The predicted risk of mortality was stratified according to the risk profile of 0.39-66.51%. When validated externally, CrOSS predicted mortality accurately (ROC = 0.847, calibration P-value = 0.199). CONCLUSIONS: A robust and simple preoperative model has been created to risk-stratify patients for colorectal surgery. This was successfully validated at another tertiary hospital.
BACKGROUND: Colorectal surgery carries a significant mortality risk, with reported rates of 1-6% for elective surgery and up to 22% in the emergency setting. Both clinicians and patients will benefit from being able to predict the likelihood of death before surgery. Recently, we have described and validated two risk stratification models for colorectal surgery, the Barwon Health 2012 and Association Française de Chirurgie models. However, these models are not suitable for assessment at patient's bedside. The purpose of this study is to develop a simplified preoperative model capable of predicting mortality following colorectal surgery. METHODS: The new model is termed Colorectal preOperative Surgical Score (CrOSS). The development and internal validation of CrOSS was performed using a prospectively maintained colorectal database. External validation was performed using retrospective data. Univariate and multivariate analyses were performed in model development. Calibration and discrimination were used for model validation. RESULTS: There were 474 and 389 consecutive colorectal surgeries at Geelong Hospital and Western Hospital. Overall mortality rates were 5.16% and 1.03%, respectively. Significant predictors for mortality were as follows: age ≥70, urgent operation, albumin ≤30 g/L and congestive heart failure (receiver operating characteristic (ROC) = 0.870, calibration P-value = 0.937). The predicted risk of mortality was stratified according to the risk profile of 0.39-66.51%. When validated externally, CrOSS predicted mortality accurately (ROC = 0.847, calibration P-value = 0.199). CONCLUSIONS: A robust and simple preoperative model has been created to risk-stratify patients for colorectal surgery. This was successfully validated at another tertiary hospital.
Authors: Joseph C Kong; Oliver Peacock; Peadar S Waters; Tim Eglinton; Satish K Warrier; Christopher Wakeman; Frank A Frizelle; Alexander G Heriot; Jacob J McCormick Journal: Langenbecks Arch Surg Date: 2020-06-12 Impact factor: 3.445
Authors: Oliver Peacock; Peadar S Waters; Joseph C Kong; Satish K Warrier; Chris Wakeman; Tim Eglinton; Declan G Murphy; Alexander G Heriot; Frank A Frizelle; Jacob J McCormick Journal: Tech Coloproctol Date: 2020-01-06 Impact factor: 3.781
Authors: Maleck Louis; Samuel A Johnston; Leonid Churilov; Ronald Ma; Nada Marhoon; Adele Burgess; Chris Christophi; Laurence Weinberg Journal: Ann Med Surg (Lond) Date: 2020-04-19
Authors: Marisa Baré; Manuel Jesús Alcantara; Maria José Gil; Pablo Collera; Marina Pont; Antonio Escobar; Cristina Sarasqueta; Maximino Redondo; Eduardo Briones; Paula Dujovne; Jose Maria Quintana Journal: BMC Health Serv Res Date: 2018-01-29 Impact factor: 2.655
Authors: Juan Manuel García-Torrecillas; María Carmen Olvera-Porcel; Manuel Ferrer-Márquez; Carmen Rosa-Garrido; Miguel Rodríguez-Barranco; María Carmen Lea-Pereira; Francisco Rubio-Gil; María-José Sánchez Journal: Int J Environ Res Public Health Date: 2020-06-12 Impact factor: 3.390